local toxicity considerations for qualifying excipients in generic drugs
Published 4 years ago • 756 plays • Length 17:18Download video MP4
Download video MP3
Similar videos
-
30:19
panel on excipient and formulation considerations
-
1:47:25
considerations in assessing generic drug products of oral dosage forms
-
21:51
safety evaluation of drug substance impurities in generics
-
25:40
impurity case studies: pharmacology/toxicology (22of28) generic drugs forum – apr. 3-4, 2019
-
1:57:52
complex generics: topical products, part 1
-
20:51
strategies to demonstrate complex excipient sameness (15of35) complex generics – sep. 25-26, 2019
-
19:10
product-specific guidances for complex generic drugs
-
20:11
topical dosage forms: emerging insights and implications for bioequivalence approaches
-
16:15
formulation assessments: general q1/q2 inquiries to supporting complex excipient sameness
-
15:00
filing review – do’s and don’ts (14/28) generic drugs forum 2017
-
1:26:21
generic drugs forum (gdf) 2024: regulatory considerations to enhance generic drug access-day 2, pt 2
-
0:41
active pharmaceuticals ingredients and excipients in pharmaceuticals
-
20:18
related impurities assessment considerations for apis in the generic complex peptide products
-
2:09
can pharmacies switch your prescription to generic drugs?
-
3:01
excipient functions and critical quality attributes
-
2:21
gmps for pharmaceutical excipients - section 4 of 6
-
1:00
excipients 101: an introduction to excipients! #pharmaceutical #excipients #science
-
10:49
d1,s4b,s1-characterization of excipients in complex dosage forms – fda research & goals
-
17:34
what’s new in the inactive ingredient database (iid)?